Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 227

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 227
---
 breaches (or threatened breaches) of the Merger Agreement and to enforce specifically the terms of the Merger Agreement, without bond or
other security being required.

While Enfusion will be entitled to pursue both a grant of specific performance and the payment of monetary
damages, under no circumstances will Enfusion be entitled to both (1) obtain an order for specific performance to enforce Clearwater’s obligations to consummate the Closing and (2) receive monetary damages.

Governing Law

The Merger Agreement is governed by Delaware law, except that any legal proceeding by or against any party related to the Debt Financing,
arising out of or relating to the Merger Agreement, the Debt Financing or any of the agreements entered into in connection with the Debt Financing or any of the transactions contemplated thereby or the performance of any services thereunder will be
governed by New York law.

144

THE SUPPORT AGREEMENTS The discussion of the terms of the Support Agreements in this section and elsewhere in this Proxy Statement/Prospectus is qualified in its entirety by reference to the complete text of the form of Support Agreement, a copy of which is attached as Annex B to this Proxy Statement/Prospectus and is incorporated into this Proxy Statement/Prospectus by reference. This summary does not purport to be complete and may not contain all of the information about the Support Agreements that is important to you. You are encouraged to read the form of Support Agreement carefully and in its entirety. Concurrently with the execution and delivery of the Merger Agreement on January 10, 2025, and as a condition and inducement to Clearwater’s willingness to enter into the Merger Agreement, Clearwater entered into Support Agreements with each of the Significant Stockholders. Pursuant to its Support Agreement, each of the Significant Stockholders agreed, until the earlier to occur of the Effective Time and the valid termination of the Support Agreement in accordance with its terms, among other things, to:

| • |     | affirmatively vote all of the shares of (i) Enfusion Common Stock, (ii) Enfusion Class B Common                                                                                                                          
 Stock and (iii) Enfusion Common Units (all such shares and units beneficially owned by such Significant Stockholder, the “Subject Shares”), in favor of approving and adopting the Merger Agreement and the transactions 
 contemplated thereby; and/or                                                                                                                                                                                             |

| • |     | except as otherwise permitted by the Support Agreement, vote against: |

| • |     | any action or agreement